RenovaCare, Inc.
RCAROTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$8735
P/E Ratio—
52W High$0.0002
52W Low$0.0001
RenovaCare, Inc. (RCAR) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
RCAR · earnings · updated Jun 9, 2026
Latest Earnings
Q4 FY2022Report Date: Nov 18, 2022EPS Actual
$0.01
Revenue
—
Fiscal Period
Q4 FY2022
FY ends December
Report Date
Nov 18, 2022
After Market Close
RCAR reports quarterly as a OTC-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q4 FY2022 | Nov 18, 2022 | — | $0.01 | — | — | — | — |
| — Q3 FY2022 | Aug 12, 2022 | — | -$0.03 | — | — | — | — |
| — Q2 FY2022 | May 12, 2022 | — | -$0.02 | — | — | — | — |
| — Q4 FY2021 | Dec 31, 2021 | — | -$0.02 | — | — | — | — |
| — Q4 FY2021 | Nov 12, 2021 | — | -$0.02 | — | — | — | — |
| — Q3 FY2021 | Aug 3, 2021 | — | -$0.01 | — | — | — | — |
| — Q2 FY2021 | May 7, 2021 | — | -$0.01 | — | — | — | — |
| — Q4 FY2020 | Dec 31, 2020 | — | -$0.03 | — | — | — | — |
Q4 FY2022
Nov 18, 2022
EPS Actual
$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2022
Aug 12, 2022
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2022
May 12, 2022
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2021
Dec 31, 2021
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2021
Nov 12, 2021
EPS Actual
-$0.02
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2021
Aug 3, 2021
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2021
May 7, 2021
EPS Actual
-$0.01
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2020
Dec 31, 2020
EPS Actual
-$0.03
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $1.54 | $1.54 | $1.54 | 1 |
| Q2 FY2024 | $1.34 | $1.34 | $1.34 | 1 |
| Q1 FY2024 | $1.58 | $1.58 | $1.58 | 1 |
| Q4 FY2023 | $2.09 | $2.09 | $2.09 | 1 |
| Q3 FY2023 | $1.39 | $1.39 | $1.39 | 1 |
| Q2 FY2023 | $1.19 | $1.19 | $1.19 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2024 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q4 FY2022 | Nov 18, 2022 | — | $0.01 | $0.02 | +72.91% |
| — Q3 FY2022 | Aug 12, 2022 | — | $0.05 | $0.05 | +0.00% |
| — Q2 FY2022 | May 12, 2022 | — | $0.06 | $0.06 | +0.00% |
| — Q4 FY2021 | Dec 31, 2021 | — | $0.29 | $0.28 | -2.95% |
| — Q4 FY2021 | Nov 12, 2021 | — | $1.01 | $0.98 | -2.97% |
| — Q3 FY2021 | Aug 3, 2021 | — | $1.70 | $1.70 | +0.00% |
| — Q2 FY2021 | May 7, 2021 | — | $2.81 | $2.75 | -2.14% |
| — Q4 FY2020 | Dec 31, 2020 | — | $3.09 | $2.80 | -9.39% |
Q4 FY2022+72.91%
Report Date
Nov 18, 2022
EPS Beat/Miss
—
Price Before
$0.01
Price After
$0.02
Q3 FY2022+0.00%
Report Date
Aug 12, 2022
EPS Beat/Miss
—
Price Before
$0.05
Price After
$0.05
Q2 FY2022+0.00%
Report Date
May 12, 2022
EPS Beat/Miss
—
Price Before
$0.06
Price After
$0.06
Q4 FY2021-2.95%
Report Date
Dec 31, 2021
EPS Beat/Miss
—
Price Before
$0.29
Price After
$0.28
Q4 FY2021-2.97%
Report Date
Nov 12, 2021
EPS Beat/Miss
—
Price Before
$1.01
Price After
$0.98
Q3 FY2021+0.00%
Report Date
Aug 3, 2021
EPS Beat/Miss
—
Price Before
$1.70
Price After
$1.70
Q2 FY2021-2.14%
Report Date
May 7, 2021
EPS Beat/Miss
—
Price Before
$2.81
Price After
$2.75
Q4 FY2020-9.39%
Report Date
Dec 31, 2020
EPS Beat/Miss
—
Price Before
$3.09
Price After
$2.80
Beat Rate0 / 8 quarters
Largest Move+72.91% (Q4 FY2022)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: RCAR ends December
RenovaCare, Inc. (RCAR) most recently reported earnings on November 18, 2022 for Q4 FY2022, posting EPS of $0.01 (in line with the analyst consensus of —). The next RCAR earnings date is expected around September 1, 2026.
Each quarter, investors track RCAR earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. RCAR revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
RCAR's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
RCAR earnings · 4 questionsRenovaCare, Inc.'s next earnings report is expected around September 1, 2026. RCAR typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; RCAR historically reports after market close (AMC).
RCAR earnings datewhen is RCAR earningsRCAR next earnings datewhen does RCAR report earningsRCAR earnings calendar
▸ Source: FMP · RenovaCare, Inc. SEC filings · US GAAP · RenovaCare, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026